home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  November 22, 2024
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 460 active entries

swissfillon AG

Postfach 513
Vsip, 3930
Switzerland

Phone: +41279480860
E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.

Description:

 

HIGH QUALITY DRIVEN ASEPTIC FILL AND FINISH CMO

Toxicology, Clinical Trial, and Commercial Manufacturing

Our innovative medium speed line using isolator latest technologies will fulfill your quality by design development projects and satisfy your risk-based regulations.

Real Flexibility: we are adapting and designing our processes and combo disposable equipments to fit your needs.

Documentation management: we deliver appropriate technical validation and documentation using our 10 years engineering experience.

Faster lead times to manufacture: our unique production planning system gives you the optimal production slot respecting your clinical trials plan deadlines



Selected Categories:
Product Company   Service Company
Biopharma
- General
- Research
Pharmaceutical
- General
- Research
Consulting
- General
- Strategic
Contract
- Production

Last update of this entry: August 11, 2014

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.